Biotech startups that raised Series C in the United Kingdom
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Microbiotica | Cambridge | Series C | $47.9M | 2026-10-16 |
| Basecamp Research | London | Series C | $140.0M | 2026-09-23 |
| Automata | London | Series C | $45.0M | 2026-06-25 |
| Brainomix | Oxford | Series C | $6.5M | 2026-02-24 |
| Nuclera | Cambridge | Series C | $12.0M | 2026-01-13 |
| Genomics | Oxford | Series C | $44.6M | 2024-01-08 |
| Apollo Therapeutics | Cambridge | Series C | $33.5M | 2024-01-02 |
| Metrion Biosciences | Cambridge | Series C | $4.7M | 2023-12-20 |
8 rows of the CSV in 5 of its 18 columns.
- The 38 biotech startups in the United Kingdom whose last round is Series C have raised $3.1B in total.
- 8 of them closed their most recent round in the last 12 months, $722.4M combined.
- The largest of those rounds is OMass Therapeutics' $310.0M Series C, dated October 2026.
- The most recent is Microbiotica's $47.9M Series C on 16 October 2026.
- Innovate UK is an investor in 4 of them, more than any other fund.
- Health care is the most common other sector, with 32 companies (84%).
- 0% were founded in 2020 or later; the median founding year is 2012.
- The most common team size is 11 to 50 employees (50% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
7 of 38| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Microbiotica | Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. | Biotech | Cambridge | Series C | $47.9M | 2026-10-16 | $130.7M | Seventure Partners, IP Group, Cambridge Innovation Capital +1 | 11 to 50 | 2016 |
| Basecamp Research | Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. | Artificial intelligence | London | Series C | $140.0M | 2026-09-23 | $219.9M | True Ventures, redalpine, Hummingbird Ventures +1 | 51 to 100 | 2019 |
| Automata | Automata provides laboratory automation software and hardware to increase efficiency in scientific workflows. | Artificial intelligence | London | Series C | $45.0M | 2026-06-25 | $144.8M | Octopus Ventures, Firstminute Capital, Hummingbird Ventures +1 | 101 to 250 | 2015 |
| Brainomix | Brainomix creates AI-powered imaging biomarkers that support precision medicine treatment decisions. | Artificial intelligence | Oxford | Series C | $6.5M | 2026-02-24 | $60.2M | Innovate UK, Parkwalk Advisors, Boehringer Ingelheim Venture Fund +1 | 51 to 100 | 2010 |
| Nuclera | Nuclera provides a protein prototyping system that makes proteins readily available to drug discovery researchers. | Biotech | Cambridge | Series C | $12.0M | 2026-01-13 | $157.8M | Innovate UK, Verve Ventures, Amadeus Capital Partners +2 | 101 to 250 | 2013 |
| Genomics | Genomics plc works to bring genomic medicine into healthcare. | Biotech | Oxford | Series C | $44.6M | 2024-01-08 | $135.4M | Innovate UK, IP Group, Oxford Science Enterprises +1 | 101 to 250 | 2014 |
| Apollo Therapeutics | Apollo Therapeutics develops medicines by translating medical research into biopharmaceutical portfolios. | Biotech | Cambridge | Series C | $33.5M | 2024-01-02 | $397.9M | UCL Technology Fund, Patient Square Capital, Rock Springs Capital | 51 to 100 | 2016 |
Table 1. Biotech startups that raised Series C in the United Kingdom: the 7 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 38.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Basecamp Research | Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. | Artificial intelligence | London | Series C | $140.0M | 2026-09-23 | $219.9M | True Ventures, redalpine, Hummingbird Ventures +1 | 51 to 100 | 2019 |
| 2 | Microbiotica | Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. | Biotech | Cambridge | Series C | $47.9M | 2026-10-16 | $130.7M | Seventure Partners, IP Group, Cambridge Innovation Capital +1 | 11 to 50 | 2016 |
| 3 | Automata | Automata provides laboratory automation software and hardware to increase efficiency in scientific workflows. | Artificial intelligence | London | Series C | $45.0M | 2026-06-25 | $144.8M | Octopus Ventures, Firstminute Capital, Hummingbird Ventures +1 | 101 to 250 | 2015 |
| 4 | Nuclera | Nuclera provides a protein prototyping system that makes proteins readily available to drug discovery researchers. | Biotech | Cambridge | Series C | $12.0M | 2026-01-13 | $157.8M | Innovate UK, Verve Ventures, Amadeus Capital Partners +2 | 101 to 250 | 2013 |
| 5 | Brainomix | Brainomix creates AI-powered imaging biomarkers that support precision medicine treatment decisions. | Artificial intelligence | Oxford | Series C | $6.5M | 2026-02-24 | $60.2M | Innovate UK, Parkwalk Advisors, Boehringer Ingelheim Venture Fund +1 | 51 to 100 | 2010 |
Table 2. Biotech startups that raised Series C in the United Kingdom: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Innovate UK | Entrepreneurship program | Swindon, United Kingdom | 4 | 11% | 2 | Brainomix, Nuclera |
| 2 | IP Group | Venture capital firm | London, United Kingdom | 2 | 5% | 1 | Microbiotica |
| 3 | Hummingbird Ventures | Venture capital firm | Brussels, Belgium | 2 | 5% | 2 | Basecamp Research, Automata |
| 4 | Amadeus Capital Partners | Venture capital firm | Cambridge, United Kingdom | 2 | 5% | 1 | Nuclera |
| 5 | Future Planet Capital | Venture capital firm | London, United Kingdom | 2 | 5% | 1 | Nuclera |
| 6 | British Patient Capital | Venture capital firm | Sheffield, United Kingdom | 1 | 3% | 1 | Microbiotica |
| 7 | Seventure Partners | Venture capital firm | Paris, France | 1 | 3% | 1 | Microbiotica |
| 8 | Cambridge Innovation Capital | Venture capital firm | Cambridge, United Kingdom | 1 | 3% | 1 | Microbiotica |
| 9 | True Ventures | Venture capital firm | Palo Alto, United States | 1 | 3% | 1 | Basecamp Research |
| 10 | redalpine | Venture capital firm | Zürich, Switzerland | 1 | 3% | 1 | Basecamp Research |
| 11 | Blue Horizon Corporation | Private equity firm | Zürich, Switzerland | 1 | 3% | 1 | Basecamp Research |
| 12 | Firstminute Capital | Venture capital firm | London, United Kingdom | 1 | 3% | 1 | Automata |
| 13 | Octopus Ventures | Venture capital firm | London, United Kingdom | 1 | 3% | 1 | Automata |
| 14 | Blue Wire Capital | Venture capital firm | London, United Kingdom | 1 | 3% | 1 | Automata |
| 15 | Parkwalk Advisors | Venture capital firm | London, United Kingdom | 1 | 3% | 1 | Brainomix |
Table 3. Biotech startups that raised Series C in the United Kingdom: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 32 | 84% | $2.8B |
| Software | 5 | 13% | $505.9M |
| Artificial intelligence | 3 | 8% | $424.9M |
| Hardware | 2 | 5% | $144.8M |
Table 4. Biotech startups that raised Series C in the United Kingdom by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series C | 38 | 100% | $35.0M |
Table 5. Biotech startups that raised Series C in the United Kingdom by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| London | 10 | 26% |
| Cambridge | 8 | 21% |
| Oxford | 5 | 13% |
| Glasgow | 2 | 5% |
| Stevenage | 2 | 5% |
| Abingdon | 2 | 5% |
| Macclesfield | 1 | 3% |
| Chesham | 1 | 3% |
| Bellshill | 1 | 3% |
| Preston | 1 | 3% |
| Cardiff | 1 | 3% |
| Reading | 1 | 3% |
Table 6. Biotech startups that raised Series C in the United Kingdom by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 2 | 25% | $357.9M |
| September 2026 | 1 | 12% | $140.0M |
| June 2026 | 1 | 12% | $45.0M |
| April 2026 | 1 | 12% | $56.0M |
| March 2026 | 1 | 12% | $105.0M |
| February 2026 | 1 | 12% | $6.5M |
| January 2026 | 1 | 12% | $12.0M |
Table 7. Biotech startups that raised Series C in the United Kingdom: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 8 | 21% | $722.4M |
| 2024 | 3 | 8% | $78.1M |
| 2023 | 1 | 3% | $4.7M |
| 2022 | 2 | 5% | $137.0M |
| 2021 | 5 | 13% | $146.7M |
| 2020 | 2 | 5% | $52.9M |
Table 8. Biotech startups that raised Series C in the United Kingdom by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2015 to 2019 | 12 | 32% |
| 2010 to 2014 | 12 | 32% |
| Before 2010 | 14 | 37% |
Table 9. Biotech startups that raised Series C in the United Kingdom by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 2 | 5% |
| 11 to 50 | 19 | 50% |
| 51 to 100 | 10 | 26% |
| 101 to 250 | 6 | 16% |
| 1,001 to 5,000 | 1 | 3% |
Table 10. Biotech startups that raised Series C in the United Kingdom by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series C and its headquarters is in the United Kingdom. On 16 November 2026 that is 38 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 7 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 38 rows: 3 have no round amount, 0 no city and 15 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in the United Kingdom whose last round is Series C are on the list?
- 38, in the file dated 16 November 2026. 8 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 38 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.